Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Sees Global Regulatory "Tightening," Not FDA "Slowdown"

Executive Summary

The recent signs of tougher product reviews by global regulators reflect the need for better post-marketing surveillance in light of accelerated pharmaceutical development timelines, Roche suggested during an Aug. 16 media briefing in New York City.
Advertisement

Related Content

Accutane Psychiatric Safety Trial Planned: Roche Prepares For Hearings
Roche Sees Pegasys Approval Delay Until 2002, But With Broader Indication
Accutane Psychiatric Safety Trial Planned: Roche Prepares For Hearings
Roche Sees Pegasys Approval Delay Until 2002, But With Broader Indication
Advertisement
UsernamePublicRestriction

Register

PS038382

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel